Laddar...
Targeting Bruton’s Tyrosine Kinase in CLL
Targeting the B-cell receptor signaling pathway through BTK inhibition proved to be effective for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell lymphomas. Covalent BTK inhibitors (BTKis) led to an unprecedented improvement in outcome in CLL, in particular for high-risk subgrou...
Sparad:
| I publikationen: | Front Immunol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8261291/ https://ncbi.nlm.nih.gov/pubmed/34248972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.687458 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|